Standardization, multi-vendor readiness, and analysis tool accessibility for these techniques

In the present era of “big data” and personalized medicine, a candidate biomarker needs to be available and standardized across MRI platforms in order for it to be ready for multi-center studies and clinical trials. Therefore, our goal is to standardize above techniques across MRI vendors and to determine benchmarks such as repeatability (test-retest on the same scanner) and reproducibility (on different scanners). Furthermore, to ensure compatibility of data analysis, we are developing fully automated processing pipelines that will be made available to other researchers through their deployments on our MRICloud.